Particle.news

Download on the App Store

Global Review Links Shingles Vaccine to Lower Risk of Heart Attack, Stroke

Presented at the ESC Congress in Madrid, the analysis reports modest absolute benefits, prompting calls for randomized trials.

Overview

  • In pooled data, vaccination was associated with an 18% lower risk of major cardiovascular events in adults 18+ and a 16% reduction in adults 50+.
  • Studies that reported absolute risk showed 1.2 to 2.2 fewer heart attacks or strokes per 1,000 person‑years among vaccinated people.
  • The review included 19 studies, with eight observational studies and one randomized trial that was not designed to assess cardiovascular outcomes.
  • Evidence remains largely observational and the research was funded by GSK, with authors and independent experts emphasizing that causation is unproven.
  • The findings coincide with NHS England expanding shingles vaccine eligibility next week to about 300,000 additional immunocompromised adults aged 18 to 49.